Review



easystep cd138 + magnetic nanoparticles  (STEMCELL Technologies Inc)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    STEMCELL Technologies Inc easystep cd138 + magnetic nanoparticles
    a Chemical structure of YL064. b U266 and MM1.S cells were treated with the indicated concentrations of YL064 for 24 h and apoptotic cells were evaluated by Annexin V/PI double-staining assay. ** p < 0.01, compared with control annexin V+/PI– cells, ## p < 0.01, compared with control annexin V+/PI+ cells. c U266 and MM1.S cells were untreated or treated with indicated concentrations of YL064 for 24 h. The indicated proteins were detected by western blot. d Primary <t>CD138</t> + MM cells were treated with YL064 (20 μM) for 24 h and CD138 + apoptotic cells were evaluated by Annexin V/PI double-staining assay. ** p < 0.01, compared with control annexin V+/PI– cells, # p < 0.05, ## p < 0.01, compared with control annexin V+/PI+ cells. e Primary PBMCs cells from healthy donors were treated with the indicated concentrations of YL064 (40 μM) for 24 h and cell viability was evaluated by Trypan blue exclusion assay
    Easystep Cd138 + Magnetic Nanoparticles, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/easystep cd138 + magnetic nanoparticles/product/STEMCELL Technologies Inc
    Average 90 stars, based on 1 article reviews
    easystep cd138 + magnetic nanoparticles - by Bioz Stars, 2026-05
    90/100 stars

    Images

    1) Product Images from "YL064 directly inhibits STAT3 activity to induce apoptosis of multiple myeloma cells"

    Article Title: YL064 directly inhibits STAT3 activity to induce apoptosis of multiple myeloma cells

    Journal: Cell Death Discovery

    doi: 10.1038/s41420-018-0108-8

    a Chemical structure of YL064. b U266 and MM1.S cells were treated with the indicated concentrations of YL064 for 24 h and apoptotic cells were evaluated by Annexin V/PI double-staining assay. ** p < 0.01, compared with control annexin V+/PI– cells, ## p < 0.01, compared with control annexin V+/PI+ cells. c U266 and MM1.S cells were untreated or treated with indicated concentrations of YL064 for 24 h. The indicated proteins were detected by western blot. d Primary CD138 + MM cells were treated with YL064 (20 μM) for 24 h and CD138 + apoptotic cells were evaluated by Annexin V/PI double-staining assay. ** p < 0.01, compared with control annexin V+/PI– cells, # p < 0.05, ## p < 0.01, compared with control annexin V+/PI+ cells. e Primary PBMCs cells from healthy donors were treated with the indicated concentrations of YL064 (40 μM) for 24 h and cell viability was evaluated by Trypan blue exclusion assay
    Figure Legend Snippet: a Chemical structure of YL064. b U266 and MM1.S cells were treated with the indicated concentrations of YL064 for 24 h and apoptotic cells were evaluated by Annexin V/PI double-staining assay. ** p < 0.01, compared with control annexin V+/PI– cells, ## p < 0.01, compared with control annexin V+/PI+ cells. c U266 and MM1.S cells were untreated or treated with indicated concentrations of YL064 for 24 h. The indicated proteins were detected by western blot. d Primary CD138 + MM cells were treated with YL064 (20 μM) for 24 h and CD138 + apoptotic cells were evaluated by Annexin V/PI double-staining assay. ** p < 0.01, compared with control annexin V+/PI– cells, # p < 0.05, ## p < 0.01, compared with control annexin V+/PI+ cells. e Primary PBMCs cells from healthy donors were treated with the indicated concentrations of YL064 (40 μM) for 24 h and cell viability was evaluated by Trypan blue exclusion assay

    Techniques Used: Double Staining, Control, Western Blot, Trypan Blue Exclusion Assay



    Similar Products

    easystep cd138 + magnetic nanoparticles  (STEMCELL Technologies Inc)
    90
    STEMCELL Technologies Inc easystep cd138 + magnetic nanoparticles
    a Chemical structure of YL064. b U266 and MM1.S cells were treated with the indicated concentrations of YL064 for 24 h and apoptotic cells were evaluated by Annexin V/PI double-staining assay. ** p < 0.01, compared with control annexin V+/PI– cells, ## p < 0.01, compared with control annexin V+/PI+ cells. c U266 and MM1.S cells were untreated or treated with indicated concentrations of YL064 for 24 h. The indicated proteins were detected by western blot. d Primary <t>CD138</t> + MM cells were treated with YL064 (20 μM) for 24 h and CD138 + apoptotic cells were evaluated by Annexin V/PI double-staining assay. ** p < 0.01, compared with control annexin V+/PI– cells, # p < 0.05, ## p < 0.01, compared with control annexin V+/PI+ cells. e Primary PBMCs cells from healthy donors were treated with the indicated concentrations of YL064 (40 μM) for 24 h and cell viability was evaluated by Trypan blue exclusion assay
    Easystep Cd138 + Magnetic Nanoparticles, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/easystep cd138 + magnetic nanoparticles/product/STEMCELL Technologies Inc
    Average 90 stars, based on 1 article reviews
    easystep cd138 + magnetic nanoparticles - by Bioz Stars, 2026-05
    90/100 stars
    		  Buy from Supplier
    easystep cd138+ magnetic nanoparticles  (STEMCELL Technologies Inc)
    90
    STEMCELL Technologies Inc easystep cd138+ magnetic nanoparticles
    a Chemical structure of YL064. b U266 and MM1.S cells were treated with the indicated concentrations of YL064 for 24 h and apoptotic cells were evaluated by Annexin V/PI double-staining assay. ** p < 0.01, compared with control annexin V+/PI– cells, ## p < 0.01, compared with control annexin V+/PI+ cells. c U266 and MM1.S cells were untreated or treated with indicated concentrations of YL064 for 24 h. The indicated proteins were detected by western blot. d Primary <t>CD138</t> + MM cells were treated with YL064 (20 μM) for 24 h and CD138 + apoptotic cells were evaluated by Annexin V/PI double-staining assay. ** p < 0.01, compared with control annexin V+/PI– cells, # p < 0.05, ## p < 0.01, compared with control annexin V+/PI+ cells. e Primary PBMCs cells from healthy donors were treated with the indicated concentrations of YL064 (40 μM) for 24 h and cell viability was evaluated by Trypan blue exclusion assay
    Easystep Cd138+ Magnetic Nanoparticles, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/easystep cd138+ magnetic nanoparticles/product/STEMCELL Technologies Inc
    Average 90 stars, based on 1 article reviews
    easystep cd138+ magnetic nanoparticles - by Bioz Stars, 2026-05
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    a Chemical structure of YL064. b U266 and MM1.S cells were treated with the indicated concentrations of YL064 for 24 h and apoptotic cells were evaluated by Annexin V/PI double-staining assay. ** p < 0.01, compared with control annexin V+/PI– cells, ## p < 0.01, compared with control annexin V+/PI+ cells. c U266 and MM1.S cells were untreated or treated with indicated concentrations of YL064 for 24 h. The indicated proteins were detected by western blot. d Primary CD138 + MM cells were treated with YL064 (20 μM) for 24 h and CD138 + apoptotic cells were evaluated by Annexin V/PI double-staining assay. ** p < 0.01, compared with control annexin V+/PI– cells, # p < 0.05, ## p < 0.01, compared with control annexin V+/PI+ cells. e Primary PBMCs cells from healthy donors were treated with the indicated concentrations of YL064 (40 μM) for 24 h and cell viability was evaluated by Trypan blue exclusion assay

    Journal: Cell Death Discovery

    Article Title: YL064 directly inhibits STAT3 activity to induce apoptosis of multiple myeloma cells

    doi: 10.1038/s41420-018-0108-8

    Figure Lengend Snippet: a Chemical structure of YL064. b U266 and MM1.S cells were treated with the indicated concentrations of YL064 for 24 h and apoptotic cells were evaluated by Annexin V/PI double-staining assay. ** p < 0.01, compared with control annexin V+/PI– cells, ## p < 0.01, compared with control annexin V+/PI+ cells. c U266 and MM1.S cells were untreated or treated with indicated concentrations of YL064 for 24 h. The indicated proteins were detected by western blot. d Primary CD138 + MM cells were treated with YL064 (20 μM) for 24 h and CD138 + apoptotic cells were evaluated by Annexin V/PI double-staining assay. ** p < 0.01, compared with control annexin V+/PI– cells, # p < 0.05, ## p < 0.01, compared with control annexin V+/PI+ cells. e Primary PBMCs cells from healthy donors were treated with the indicated concentrations of YL064 (40 μM) for 24 h and cell viability was evaluated by Trypan blue exclusion assay

    Article Snippet: The CD138-positive cells were selected using EasyStep CD138 + magnetic nanoparticles from MNCs (Stem Cell Technologies, Vancouver, BC, Canada) according to the manufacturer’s instructions.

    Techniques: Double Staining, Control, Western Blot, Trypan Blue Exclusion Assay